The burden of HIV: Insights from the global burden of disease study 2010

AIDS

Volumn 27, Issue 13, 2013, Pages 2003-2017

  Ortblad, Katrina F ^a   Lozano, Rafael ^a   Murray, Christopher J L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Burden; Disability adjusted life years; Global Burden of Disease Study; Global trends; HIV AIDS; Mortality

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME NURSING; ADULT; AGE DISTRIBUTION; BODY BURDEN; BODY WEIGHT; CENTRAL AFRICA; CENTRAL AMERICA; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE INDEX; REGISTRATION; REVIEW; SOUTH AFRICA; THAILAND;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; SURVIVAL ANALYSIS; WORLD HEALTH;

EID: 84884485861     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328362ba67     Document Type: Review

References (50)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regionalmortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095-2128.
2. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2197-2223.
3. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2163-2196.
4. WHO. Global status report on noncommunicable diseases 2010. Geneva, Switzerland: WHO; 2011.
5. UNAIDS. UNAIDS Report on the Global AIDS Epidemic: 2012. Geneva, Switzerland: UNAIDS; 2011.
6. UNAIDS. 2012 progress reports submitted by countries [Internet]. Geneva, Switzerland: UNAIDS; 2012.
7. UNAIDS. UNAIDS: the first 10 years [Internet]. Geneva, Switzerland: UNAIDS; 2008.
8. GFATM. Our history - the global fund to fight AIDS, tuberculosis and malaria [Internet] [cited 12 April 2013]. http://www. theglobalfund.org/en/ about/history/ [Accessed 12 April 2013].
9. PEPFAR Watch. About PEPFAR | PEPFAR watch [Internet] [cited 12 April 2013]. http://www.pepfarwatch.org/about-pepfar/ [Accessed 12 April 2013].
10. El-Sadr WM, Holmes CB, Mugyenyi P, Thirumurthy H, Ellerbrock T, Ferris R, et al. Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr 2012; 60 (Suppl 3):S96-S104.
11. Stover J, Korenromp EL, Blakley M, Komatsu R, Viisainen K, Bollinger L, et al. Long-term costs and health impact of continued global fund support for antiretroviral therapy. Plos One 2011; 6:e21048.
12. A strategic revolution in HIV and global health. Lancet 2011; 377:2055.
13. UNAIDS. Together we will end AIDS. Geneva, Switzerland: UNAIDS; 2012.
14. UNAIDS. Getting to zero: 2011-2015 stratgey. Geneva, Switzerland: UNAIDS; 2010.
15. Institute for Health Metrics and Evaluation. Financing global health 2012: the end of the golden age? [Internet]. Seattle, WA: Institute for Health Metrics and Evaluation; 2012.
16. UNAIDS. UNAIDS report on the Global AIDS epidemic: 2010. Geneva, Switzerland: UNAIDS; 2010.
17. UNAIDS. Global HIV/AIDS response: epidemic update and health sector progress towards universal access 2011. Geneva, Switzerland: UNAIDS; 2011.
18. UNAIDS. Report on the global AIDS epidemic: 2008. Geneva, Switzerland: UNAIDS; 2008.
19. Mathers CD, Murray CJ, Ezzati M, Gakidou E, Salomon JA, Stein C. Population health metrics: crucial inputs to the development of evidence for health policy. Popul Heal Metrics 2003; 1:6.
20. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: a multiinvestigator collaboration for global comparative descriptive epidemiology. Lancet 2012; 380:2055-2058.
21. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet 2012; 380:2063-2066.
22. Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, Levin-Rector A, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2071-2094.
23. SalomonJA,Vos T,HoganDR,GagnonM,NaghaviM,MokdadA, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012; 380:2129-2143.
24. Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 2012; 380:2144-2162.
25. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2224-2260.
26. Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Heal Metrics 2012; 10:1.
27. King G, Tomz M, Wittenberg J. Making the most of statistical analyses: improving interpretation and presentation. Am J Polit Sci 2000; 44:347-361.
28. Institute for Health Metrics and Evaluation. Critical ethical choices for DALYs meeting. Seattle, WA: Institute for Health Metrics and Evaluation; 2011.
29. WHO. WHO download data as CSV files [Internet]. WHO; 2013; [cited 12 April 2013]. http://www.who.int/tb/country/ data/download/en/index.html [Accessed 12 April 2013].
30. Stringer JSA, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006; 296:782-793.
31. Mermin J, Were W, Ekwaru JP, Moore D, Downing R, Behumbiize P, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIVuninfected children: a prospective cohort study. Lancet 2008; 371:752-759.
32. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet 2011; 378:282-284.
33. WHO Global Malaria Programme. World malaria report: 2012. Geneva, Switzerland: WHO Global Malaria Programme; 2012.
34. D'Alessandro U, Olaleye BO, McGuire W, Langerock P, Bennett S, Aikins MK, et al. Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet 1995; 345:479-483.
35. Fegan GW, Noor AM, Akhwale WS, Cousens S, Snow RW. Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study. Lancet 2007; 370:1035-1039.
36. Rasschaert F, Pirard M, Philips MP, Atun R, Wouters E, Assefa Y, et al. Positive spill-over effects of ART scale up on wider health systems development: evidence from Ethiopia and Malawi. J Int AIDS Soc 2011; 14 (Suppl 1):S3.
37. Assefa Y, Jerene D, Lulseged S, Ooms G, Van Damme W. Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects. Plos Med 2009; 6:e1000056.
38. GBD 2010 Country Collaboration. GBD 2010 country results: a global public good. Lancet 2013; 381:965-970.
39. Creese A, Floyd K, Alban A, Guinness L. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 2002; 359:1635-1643.
40. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000; 356:113-121.
41. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. Plos Med 2006; 3:e517.
42. Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011; 377:2031-2041.
43. UNAIDS. Methods for estimating HIV incidence: Epi Alert [Internet]. Geneva, Switzerland: UNAIDS; 2012.
44. UNAIDS. Methodology - understanding the latest estimates [Internet]. Geneva, Switzerland: UNAIDS; 2010.
45. Stover J, Johnson P, Zaba B, Zwahlen M, Dabis F, Ekpini RE. The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect 2008; 84 (Suppl 1):i24-i30.
46. Stover J, Johnson P, Hallett T, Marston M, Becquet R, Timaeus IM. The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans. Sex Transm Infect 2010; 86 (Suppl 2):ii16-ii21.
47. Stover J, Brown T, Marston M. Updates to the spectrum/estimation and projection package (EPP) model to estimate HIV trends for adults and children. Sex Transm Infect 2012; 88 (Suppl 2):i11-i16.
48. UNAIDS Reference Group on Estimates, Modelling and Projections. Consultation on estiamtes of mortality due to HIV/AIDS [Internet]. Geneva, Switzerland: UNAIDS; 2012.
49. Rajaratnam JK, Marcus JR, Levin-Rector A, Chalupka AN, Wang H, Dwyer L, et al. Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet 2010; 375:1704-1720.
50. Lozano R, Ortblad KF, Lopez AD, Murray CJ. Mortality from HIV in the Global Burden of Disease study - authors' reply. Lancet 2013; 381:991-992.